What's breaking now, across thousands of outlets.
Merck reported Thursday its dual GLP-1/glucagon agonist cleared a mid-stage trial in the liver disease called MASH, sharing biopsy data on a drug it licensed from Hanmi Pharmaceutical in 2020 for $10 ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing
After building a healthcare conglomerate around a drugstore chain, CVS is dismantling the model with drug stores on one side and healthcare solutions on the other.
From healthier skin to sharper thinking, here are 13 reasons why staying hydrated is essential during South Africa's scorching summer.
When people could see a man’s full body on video, digitally deepening his voice made him seem stronger and more dominant, but not more attractive to women, a study in Royal Society Open Science found.
Experts have said the US-funded trial would deny critical vaccines to thousands of infants.
Mumbai: The Maharashtra Food and Drug Administration (FDA) has collected a sample of gold-plated sweets being sold for Rs 24,000 per kg in Amravati after questioning whether the expensive…
